Bond Amgen 8.125% ( US031162AA80 ) in USD
| Issuer | Amgen | ||||||||||
| Market price | |||||||||||
| Country | United States
|
||||||||||
| ISIN code |
US031162AA80 ( in USD )
|
||||||||||
| Interest rate | 8.125% per year ( payment 2 times a year) | ||||||||||
| Maturity | 01/04/2097 | ||||||||||
|
Prospectus brochure in PDF format |
|||||||||||
| Minimal amount | 1 000 USD | ||||||||||
| Total amount | 100 000 000 USD | ||||||||||
| Cusip | 031162AA8 | ||||||||||
| Standard & Poor's ( S&P ) rating | BBB+ ( Lower medium grade - Investment-grade ) | ||||||||||
| Moody's rating | Baa1 ( Lower medium grade - Investment-grade ) | ||||||||||
| Next Coupon | 01/10/2026 ( In 17 days ) | ||||||||||
| Detailed description |
Amgen is a leading biotechnology company focused on developing and delivering innovative therapies for serious illnesses in areas such as oncology, cardiovascular disease, and inflammation. The Bond issued by Amgen ( United States ) , in USD, with the ISIN code US031162AA80, pays a coupon of 8.125% per year. The coupons are paid 2 times per year and the Bond maturity is 01/04/2097 The Bond issued by Amgen ( United States ) , in USD, with the ISIN code US031162AA80, was rated Baa1 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Amgen ( United States ) , in USD, with the ISIN code US031162AA80, was rated BBB+ ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||||
| |||||||||||
Français
Italiano
United States